What is the significance and appropriate management of Mycoplasma isolated from a urine culture?

Mycoplasma in Urine Culture: Clinical Significance and Management

Mycoplasma isolated from urine culture most commonly represents genital tract colonization rather than true urinary tract infection, but when associated with pyuria and upper tract symptoms (fever, flank pain), it should be treated as a pathogen causing pyelonephritis, particularly Mycoplasma hominis.

Clinical Context and Pathogenicity

The significance of Mycoplasma in urine depends critically on the clinical presentation and species identified:

Mycoplasma hominis

• M. hominis is the primary urinary pathogen among Mycoplasma species and has been documented to cause acute pyelonephritis, particularly in patients with structural abnormalities or instrumentation 1, 2.
• Antibodies to M. hominis in urine have high diagnostic value for upper urinary tract infection, appearing only in patients with clinical signs of acute pyelonephritis 1.
• In one series, M. hominis was isolated from 9.6% of patients with renal disease, with the organism predominating in cases of pyelonephritis and hypertension 3.

Ureaplasma species

• U. urealyticum may cause urethritis, but its role in bladder/kidney infection remains controversial 4.
• U. parvum is generally not considered an etiological agent in urinary infections 4.
• Ureaplasma colonization is common (26% prevalence in symptomatic women) and does not always correlate with sterile pyuria 5.

Diagnostic Approach

Order Mycoplasma/Ureaplasma cultures only when:

• Standard bacterial cultures are negative ("sterile pyuria") AND
• Patient has persistent lower urinary tract symptoms or signs of pyelonephritis (fever, flank pain, costovertebral angle tenderness) 4, 1

Key diagnostic features suggesting true infection:

• Presence of pyuria (>5 WBC/hpf) with negative routine bacterial culture 1
• Upper tract symptoms: fever, flank pain, systemic signs 1, 2
• Isolation from upper urinary tract specimens (if obtained) 1
• Absence of alternative bacterial pathogens 1

Common pitfall: Do not treat asymptomatic Mycoplasma/Ureaplasma colonization, as these organisms frequently colonize the genital tract without causing disease 5.

Treatment Recommendations

For Mycoplasma genitalium (urethritis context)

• First-line: Azithromycin 500 mg PO day 1, then 250 mg PO for 4 days 4
• Macrolide-resistant: Moxifloxacin 400 mg PO daily for 7-14 days 4

For Ureaplasma urealyticum (urethritis context)

• First-line: Doxycycline 100 mg PO twice daily for 7 days 4
• Alternative: Azithromycin 1.0-1.5 g PO single dose 4

For Mycoplasma hominis (pyelonephritis)

• First-line: Doxycycline or tetracycline (M. hominis shows high sensitivity to tetracyclines) 3, 2
• Alternative: Gentamicin (also shows high sensitivity) 3
• Treatment duration: Follow complicated UTI guidelines: 7-14 days (14 days for males when prostatitis cannot be excluded) 4
• Critical note: M. hominis is intrinsically resistant to macrolides; do not use azithromycin 2

Antibiotic Resistance Patterns

• Tetracycline resistance remains low in first-time UTI patients (approximately 1.4% for U. parvum) 6
• Fluoroquinolone resistance is emerging but still uncommon (1.4% levofloxacin resistance in U. parvum) 6
• All M. hominis and U. urealyticum isolates in recent U.S. studies showed sensitivity to tested antibiotics 6
• Doxycycline maintains the lowest MIC90 (0.25 μg/ml) among Ureaplasma species 6

Management Algorithm

Step 1: Assess clinical presentation

• Lower tract symptoms only (dysuria, frequency, urgency) → Consider urethritis, not UTI
• Upper tract symptoms (fever, flank pain) → Suspect pyelonephritis

Step 2: Review urine studies

• Pyuria present + negative routine culture → Consider atypical organisms
• No pyuria → Unlikely to be infection; consider colonization

Step 3: Treatment decision

• Symptomatic with pyuria and upper tract signs: Treat as complicated UTI with doxycycline 100 mg PO twice daily for 7-14 days 4, 3
• Symptomatic lower tract only: Treat as urethritis per guidelines 4
• Asymptomatic or colonization: No treatment indicated 5

Step 4: Follow-up

• Repeat culture only if symptoms persist or recur within 4 weeks 4
• Consider longer treatment (3 months) for persistent symptoms with documented Mycoplasma/Ureaplasma, though evidence is limited 5

Special Considerations

Complicated UTI factors that increase Mycoplasma pathogenicity risk:

• Urinary tract instrumentation or catheterization 4, 2
• Structural abnormalities (stones, nephrocalcinosis) 2
• Immunosuppression 4
• Male gender (all UTIs in males are considered complicated) 4

When to suspect mixed infection:

• Severe clinical presentation with lower tract symptoms suggests possible co-infection with typical bacteria and Mycoplasma 1
• In one series, 33% of Mycoplasma-positive cultures also grew typical organisms 5